Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06628791
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-10-04
Brief Title:
BK329 and Body Fat Reduction
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effects of Oral Intake of BK329 on Body Fat Reduction in Adults With Overweight or Obesity a Randomized Double-blind Placebo-controlled Clinical Trial
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial aims to determine whether BK329 reduces body fat in adults with overweight or obesity and to assess its safety
The main questions are
Does BK329 reduce body fat in participants
What side effects occur when participants take BK329
The main questions are
Does BK329 reduce body fat in participants
What side effects occur when participants take BK329
Detailed Description:
Researchers will compare BK329 to a placebo to evaluate its effectiveness in reducing body fat
Participants will
Take BK329 or a placebo daily for 12 weeks
Visit the clinic every six weeks for checkups and tests
Participants will
Take BK329 or a placebo daily for 12 weeks
Visit the clinic every six weeks for checkups and tests
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None